SCHEMBL28879342

SCHEMBL28879342

CCCC(=O)Oc1cn(C(=O)OC(C)(C)C)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.59
EPHX1 P07099 1/20 0.46
ACHE P22303 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PIM1 P11309 1/20 0.42
MARK3 P27448 1/20 0.42
MAP4K2 Q12851 1/20 0.42
CAMK2B Q13554 1/20 0.42
PIM3 Q86V86 1/20 0.42
PIM2 Q9P1W9 1/20 0.42
HTR6 P50406 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
BRD4 O60885 1/20 0.40
CREBBP Q92793 1/20 0.40
PDE10A Q9Y233 1/20 0.40
ADAM17 P78536 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27449574 0.84 L3MBTL1 (0.54) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL16398819 0.81 L3MBTL1 (0.69) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL28795466 0.80 L3MBTL1 (0.50) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL10088115 0.79 L3MBTL1 (0.74) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL5958192 0.79 L3MBTL1 (0.51) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL7004454 0.78 L3MBTL1 (0.53) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL22651784 0.78 L3MBTL1 (0.70) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL21246900 0.78 L3MBTL1 (0.53) L3MBTL1EPHX1ACHEMEN1KMT2A
SCHEMBL28095904 0.77 NR4A2 (0.48) MEN1KMT2A
SCHEMBL28034291 0.76 KMT2A (0.56) L3MBTL1MEN1KMT2ACREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105209479-B Macrocyclic inhibitors of the PD-1/PD-L1 interaction 百时美施贵宝公司 2019-11-26 CN disclosed